Investors & Media

Investors & Media

About Kiniksa

We are a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from devastating and debilitating diseases with significant unmet medical need. We have built a pipeline of product candidates across various stages of development, currently focused on autoinflammatory and autoimmune diseases.

Stock

Price: Change: Volume:

Aug 14, 2018 9:36 PM EDT

Copyright Nasdaq. Minimum 15 minutes delayed.

Events and Presentations

08/14/18 at
12:00 AM EDT